Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05564663 · ClinicalTrials.gov registry record · NA
Testing a PTSD m-Health Intervention to Improve Alcohol Treatment Outcomes
A NA study of Post Traumatic Stress Disorder and Alcohol Use Disorder, sponsored by Michigan State University.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT05564663: Recruiting NA study of Post Traumatic Stress Disorder and Alcohol Use Disorder, sponsored by Michigan State University.
NCT05564663 is a NA study of Post Traumatic Stress Disorder and Alcohol Use Disorder that is actively recruiting participants, run by Michigan State University. The registered enrollment target is 300 participants, below the 663-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05564663, a NA study of Post Traumatic Stress Disorder and Alcohol Use Disorder, is actively recruiting participants, sponsored by Michigan State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to learn whether a mobile health application (mHealth App) for posttraumatic stress disorder (PTSD) with brief support can help individuals who are in treatment for alcohol problems.
Primary Outcome
The PCL-5 is a 20-item, self-reported measure that assesses the 20 DSM-5 symptoms of PTSD. Each symptom is measured on a 0-4 scale, with higher values indicating greater severity. Total scale scores range from 0 to 80.
Conditions Studied
Interventions
- BEHAVIORAL PTSD Coach App + Brief Support
- BEHAVIORAL Enhanced Usual Care (EUC)
Study Locations (1)
Michigan
- Pine Rest Christian Mental Health Services - Grand Rapids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2023-10-06 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
What NCT05564663 shows while recruiting
NCT05564663 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 663-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (55% lower).
The record links to 2 conditions, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which PTSD Coach App + Brief Support is the first listed.
NCT05564663 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT05564663 about?
NCT05564663 is a clinical study titled "Testing a PTSD m-Health Intervention to Improve Alcohol Treatment Outcomes". The purpose of this study is to learn whether a mobile health application (mHealth App) for posttraumatic stress disorder (PTSD) with brief support can help individuals who are in treatment for alcohol problems.
What is the current status of trial NCT05564663?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2023-10-06. Estimated completion is 2026-05-31.
What conditions does trial NCT05564663 study?
This clinical trial studies the following conditions: Post Traumatic Stress Disorder, Alcohol Use Disorder.
What interventions are being tested in trial NCT05564663?
The interventions under investigation include: PTSD Coach App + Brief Support (BEHAVIORAL), Enhanced Usual Care (EUC) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05564663?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05564663 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Traumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05564663's enrollment target sits among peer trials
300 28th of 262 higher than 230 of 262 other Post Traumatic Stress Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
RECRUITING · NA
-
TMS-fNIRS Personalized Dosing
RECRUITING · NA
-
Targeting the Default Mode Network: A TMS-fMRI Study
RECRUITING · NA
-
The Effects of Very Brief Exposure on PTSD in U.S. Combat Veterans
RECRUITING · NA
-
Fear and Avoidance in PTSD Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI